Research programme: conjugated cyclodextrin-peptide therapeutics - Targetrin Therapeutics
Alternative Names: CD-Peptide therapies; cyclodextrin-peptide therapiesLatest Information Update: 03 Feb 2021
At a glance
- Originator Targetrin Therapeutics
- Class Peptides; Peptidomimetics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research CNS disorders; Lung disorders